ZEIDMAN FRED S - 10 Jan 2022 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Role
Director
Signature
/s/ Fred Zeidman
Issuer symbol
BJDX
Transactions as of
10 Jan 2022
Transactions value $
$0
Form type
4
Filing time
13 Jan 2022, 18:36:25 UTC
Previous filing
15 Nov 2021
Next filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BJDX Option to purchase common stock Award +15K +150% 25K 10 Jan 2022 Common Stock 15K $2.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date.
F2 The stock options were issued in connection with the reporting person's Board of Director services to the Company.